124 Hikma PHarmaceuticals Plc annual report 2011 notes to the consolidated financialstatements Continued 18. available for sale investments available for sale investments represent investments in listed equity securities and unlisted securities that are recorded at fair value based on either quoted market price for similar listed companies or using other valuation methods for unlisted companies.
2011 2010 listed non-listed total listed non-listed total $000 $000 $000 $000 $000 $000 1 January 248 229 477 245 297 542 disposals 140 140 fair value adjustments recognised in equity 42 42 3 72 75 31 December 206 229 435 248 229 477 Disposals during 2010 are mainly of an investment in a non-listed us company mena innovative technologies inc. 19. financial and other non-current assets as at 31 december 2011 2010 $000 $000 other financial assets 1,644 1,357 other non-current asset 10,000 10,000 11,644 11,357 Other non-current assets represent advanced payments made to acquire products and product related technologies.
20. inventories 2011 2010 $000 $000 finished goods 77,862 50,829 work-in-progress 28,039 29,592 raw and packing materials 114,449 81,864 goods in transit 18,910 19,907 239,260 182,192 Goods in transit include inventory held at third parties whilst in transit between Group companies.
as at as at 31december acquisition of translation 31 december 2010 additions subsidiaries utilisation adjustments 2011 $000 $000 $000 $000 $000 $000 provisions against inventory 16,845 13,933 8,051 14,599 152 24,078 the total expense in the income statement for the write-off of inventory including provisions for such write offs was usD 12,271,000 2010:usD13,076,000.
